Javad Rad-Sharifi

Cuenca, A, Ecuador

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 171 publications

Bisabolol as a natural anticancer agent: molecular insights and therapeutic potential in oncology.

Bisabolol as a natural anticancer agent: molecular insights and therapeutic potential in oncology.

Journal: Medical oncology (Northwood, London, England)

Published: June 07, 2025

Apratoxin S10 as a dual-action modulator of receptor tyrosine kinases and tumor microenvironment: emerging anticancer insights from marine-derived analogs.

Apratoxin S10 as a dual-action modulator of receptor tyrosine kinases and tumor microenvironment: emerging anticancer insights from marine-derived analogs.

Journal: Medical oncology (Northwood, London, England)

Published: May 25, 2025

Salvianolic acid B in cancer therapy: pharmacokinetic profile, anticancer mechanisms and translational potential.

Salvianolic acid B in cancer therapy: pharmacokinetic profile, anticancer mechanisms and translational potential.

Journal: Medical oncology (Northwood, London, England)

Published: April 28, 2025

Epigenetic dysregulation in cancer: mechanisms, diagnostic biomarkers and therapeutic strategies.

Epigenetic dysregulation in cancer: mechanisms, diagnostic biomarkers and therapeutic strategies.

Journal: Medical oncology (Northwood, London, England)

Published: April 27, 2025

Symplocamide A as marine-derived proteasome inhibitor: a promising scaffold for targeted cancer therapy.

Symplocamide A as marine-derived proteasome inhibitor: a promising scaffold for targeted cancer therapy.

Journal: Medical oncology (Northwood, London, England)

Published: April 13, 2025

Liquid biopsy in breast cancer: clinical implications of ctDNA and CTCs in diagnosis, treatment and monitoring.

Liquid biopsy in breast cancer: clinical implications of ctDNA and CTCs in diagnosis, treatment and monitoring.

Journal: Molecular and cellular biochemistry

Published: April 11, 2025

Procyanidins as potential anticancer agents: mechanisms of action, bioavailability challenges and therapeutic opportunities.

Procyanidins as potential anticancer agents: mechanisms of action, bioavailability challenges and therapeutic opportunities.

Journal: Medical oncology (Northwood, London, England)

Published: March 17, 2025

BCMA-targeted therapies in multiple myeloma: advances, challenges and future prospects.

BCMA-targeted therapies in multiple myeloma: advances, challenges and future prospects.

Journal: Medical oncology (Northwood, London, England)

Published: March 03, 2025

Retraction Note: Development and evaluation of methotrexate-loaded nanoemulsion formulation for topical treatment of psoriasis.

Retraction Note: Development and evaluation of methotrexate-loaded nanoemulsion formulation for topical treatment of psoriasis.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: February 27, 2025

Pterostilbene as a Multifaceted Anticancer Agent: Molecular Mechanisms, Therapeutic Potential and Future Directions.

Pterostilbene as a Multifaceted Anticancer Agent: Molecular Mechanisms, Therapeutic Potential and Future Directions.

Journal: Medical oncology (Northwood, London, England)

Published: February 03, 2025

Pinosylvin as a promising natural anticancer agent: mechanisms of action and future directions in cancer therapy.

Pinosylvin as a promising natural anticancer agent: mechanisms of action and future directions in cancer therapy.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: December 27, 2024

Ingenol mebutate in cancer therapy: mechanisms, clinical applications and future directions.

Ingenol mebutate in cancer therapy: mechanisms, clinical applications and future directions.

Journal: Medical oncology (Northwood, London, England)

Published: December 10, 2024

Showing 1-12 of 171

Last Updated: 09/26/2026